Nark Ted C 4
4 · Amneal Pharmaceuticals, Inc. · Filed May 8, 2026
Research Summary
AI-generated summary of this filing
Amneal (AMRX) Director Ted C. Nark Receives RSUs on Vesting
What Happened
Ted C. Nark, a director of Amneal Pharmaceuticals (AMRX), had 34,819 restricted stock units (RSUs) vest in early May 2026. The filing shows a conversion/exercise of 34,819 derivative units (code M) and an award/acquisition of 19,824 shares (code A) reported at $0.00. The numbers indicate 19,824 shares were delivered to Nark and the difference (14,995 shares) was withheld/surrendered to satisfy taxes or similar obligations; no cash purchase or sale occurred.
Key Details
- Transaction dates: RSU grant noted as May 6, 2026 (award reported) and conversion/vesting activity reported May 7, 2026; Form 4 filed May 8, 2026.
- Transaction types/codes: A = award/acquisition of 19,824 shares; M = conversion/exercise of 34,819 RSUs (derivative). Prices reported $0.00 (no cash exchanged).
- Net shares: 19,824 shares issued to the insider; 34,819 RSUs vested in total, implying 14,995 shares were withheld/surrendered.
- Footnotes: F1—each RSU converts to one share; F2—these 34,819 RSUs were originally granted on May 6, 2025 and vested May 7, 2026; F3—vesting conditions described in filing.
- Timeliness: Form 4 was filed on May 8, 2026 for transactions on May 6–7, 2026 (appears timely under Section 16 two-business-day rule).
- Shares owned after the transactions were not stated in the excerpt provided.
Context
This was a routine equity award/vesting event rather than an open-market buy or sale. Code M (exercise/conversion) here denotes the RSUs converting into shares; the withheld/surrendered shares are commonly used to cover tax withholding or other obligations on vesting. Such award-related filings reflect compensation vesting and do not by themselves indicate the insider is buying or selling for investment purposes.
Insider Transaction Report
- Exercise/Conversion
Class A Common Stock
[F1]2026-05-07+34,819→ 325,848 total - Exercise/Conversion
Restricted Stock Units
[F1][F2]2026-05-07−34,819→ 0 total→ Class A Common Stock (34,819 underlying) - Award
Restricted Stock Units
[F1][F3]2026-05-06+19,824→ 19,824 total→ Class A Common Stock (19,824 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026.
- [F3]Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.